Prevalence and prognosis of pseudoexfoliation glaucoma in Western India

Asia-Pacific Journal of Ophthalmology

Volumn 4, Issue 2, 2015, Pages 121-127

  Rao, Vinita ^a   Doctor, Mariam ^a,b   Rao, Girish ^a  

^a Departments of Glaucoma   (India)

^b Departments of Retina   (India)

Author keywords

Glaucoma; Intraocular Pressure; Pseudoexfoliation

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CATARACT EXTRACTION; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA; HUMAN; INDIA; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; CATARACT EXTRACTION; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA; HUMANS; INDIA; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 84991270324     PISSN: None     EISSN: 21620989     Source Type: Journal    
DOI: 10.1097/APO.0b013e3182a0af43     Document Type: Article

References (57)

1. Vesti E, Kivela T. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19:345-368.
2. Orr AC, Robitaille JM, Price PA, et al. Exfoliation syndrome: clinical and genetic features. Ophthalmic Genet. 2001;22:171-185.
3. Allingham RR, Loftsdottir M, Gottfredsdottir MS, et al. Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol. 2001;85:702-707.
4. Hammer T, Schlotzer-Schrehardt U, Naumann GO. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study. Arch Ophthalmol. 2001;119:1023-1031.
5. Gartaganis SP, Georgakopoulos CD, Exarchou AM, et al. Increased aqueous humor basic fibroblast growth factor and hyaluronate levels in relation to the exfoliation syndrome and exfoliative glaucoma. Acta Ophthalmol Scand. 2001;79:572-575.
6. Hu DN, Ritch R. Increased hepatocyte growth factor concentration in aqueous humor in glaucomatous eyes. J Glaucoma. 2001;10:152-157.
7. Schlotzer-Schrehardt U, Lommatzsch J, Kuchle M, et al. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Invest Ophthalmol Visual Sci. 2003a; 132:88-123.
8. Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, et al. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol. 2002, Dec;134:879-883.
9. Lim MC, Doe EA, Vroman DT, et al. Late onset lens particle glaucoma as a consequence of spontaneous dislocation of an intraocular lens in pseudoexfoliation syndrome. Am J Ophthalmol. 2001;132:261-263.
10. Hirvela H, Luukinen H, Laatikainen L. Prevalence and risk factors of lens opacities in the elderly in Finland. A population based study. Ophthalmology. 2000;102:108-117.
11. Puska P, Tarkkanen A. Exfoliation syndrome as a risk factor for cataract development. Five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg. 2001;27:1992-1998.
12. Parodi MB, Bondel E, Saviano S, et al. Iris indocyanine green angiography in pseudoexfoliation syndrome and capsular glaucoma. Acta Ophthalmol Scand. 2000;78:437-442.
13. Puska P, Vasara K, Harju M, et al. Corneal thickness and corneal endothelium in normotensive subjects with unilateral exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2000;238:659-663.
14. Lanzl IM, Merte RL, Graham AD. Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? J Glaucoma. 2000;9:214-218.
15. Esaki K, Ito K, Matsunaga K, et al. Anterior chamber structural change in postural variation in pseudoexfoliation syndrome. Nippon Ganka Gakkai Zasshi. 2001;105:524-529.
16. Kling F, Colin J. Potential association of pseudoexfoliation syndrome with age-related macular degeneration. J Fr Ophthalmol. 2001; 24:7-12.
17. Yuksel N, Karabas VL, Arslan A, et al. Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology. 2001;108:1043-1049.
18. Harju M, VestiE. Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2001;239:271-277.
19. Mistlberger A, Gruchmann M, HitzlW, et al. Pulsatile ocular blood flow in patients with pseudoexfoliation. Spektrum Augenheilkd. 2000;14: 14-18.
20. Linner E, Popovic V, Gottfries CG, et al. The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand. 2001;79:283-285.
21. Oruc S, Orhan M, Irke-c M. Generalized iris transluminance and pseudoexfoliation syndrome in patients with transient ischemic attack and dark-colored eyes. Ann Ophthalmol. 2001;33:113-115.
22. Schumacher S, Schlotzer-Schrehardt U, Martus P, et al. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet. 2001;357:359-360.
23. Hietanen J, Soisalon-Soininen S, Kivelä T, et al. Exfoliation syndrome in patients operated for abdominal aortic aneurysm [abstract]. Acta Ophthalmol. 2000;78:290.
24. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol. 2000;129:83-86.
25. Parmaksiz S, Yuksel N, Karabas VL, et al. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma. Eur J Ophthalmol. 2006;16: 73-80.
26. Thomas R, Parikh R, Sood D, et al. Efficacy and safety of latanoprost for glaucoma treatment: a three-month multicentric study in India. Indian J Ophthalmol. 2005;53:23-30.
27. Franks WA, Renard JP, Cunliffe IA, et al. A 6-week, double-masked, parallel group study of the efficacy and safety of travoprost 0. 004% compared with latanoprost 0:005%/timolol 0. 5% in patients with primary open-angle glaucoma or ocular hypertension. Clin Ther. 2006;28:332-339.
28. Martinez A, Sanchez M. A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma. Curr Med Res Opin. 2007;23:1025-1032.
29. Petounis A, Mylopoulos N, Kandarakis A, et al. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece. J Glaucoma. 2001;10:316-324.
30. Fontana H, Nouri-Mahdavi K, Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol. 2006;141: 652-659.
31. Singh K, Mehta K, Shaikh NM, et al. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology. 2000;107:2305-2309.
32. WuDunn D, Cantor LB, Palanca-Capistrano AM, et al. A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy. Am J Ophthalmol. 2002;134:521-528.
33. Landa G, Pollack A, Rachmiel R, et al. Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243:1236-1240.
34. Gedde SJ, Herndon LW, Brandt JD, et al. Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol. 2007;143:23-31.
35. Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol. 2007;143:9-22.
36. Shingleton BJ, Heltzer J, O'Donoghue MW. Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surg. 2003;29:1080-1086.
37. Hyams M, Mathalone N, Herskovitz M, et al. Intraoperative complications of phacoemulsification in eyes with and without pseudoexfoliation. J Cataract Refract Surg. 2005;31:1002-1005.
38. Shastri L, Vasavada A. Phacoemulsification in Indian eyes with pseudoexfoliation syndrome. J Cataract Refract Surg. 2001;27: 1629-1637.
39. Gimbel HV, Condon GP, Kohnen T, et al. Late in-the-bag intraocular lens dislocation: incidence, prevention, and management. J Cataract Refract Surg. 2005;31:2193-2204.
40. Thomas R, Nirmalan PK, Krishnaiah S. Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study. Invest Ophthalmol Vis Sci. 2005;46:1170-1176.
41. Krishnadas R, Nirmalan PK, Ramakrishnan R, et al. Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey. Am J Ophthalmol. 2003;135:830-837.
42. Arvind H, Raju P, Pual PG, et al. Pseudoexfoliation in south India. Br J Ophthalmol. 2003;87:1321-1323.
43. Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110:1484-1490.
44. Wishart PK, Spaeth GL, Poryzees EM. Anterior chamber angle in the exfoliation syndrome. Br J Ophthalmol. 1985;69:103-105.
45. Mitchell P, Wanf JJ, Smith W. Association of pseudoexfoliation with increased vascular risk. Am J Ophthalmol. 1997;124:685-687.
46. Hiller R, Sperduto RD, Krueger DE. Pseudoexfoliation, intraocular pressure and senile changes in a population based survey. Arch Ophthalmol. 1982;100:1080-1082.
47. Lemoine AN. Glaucoma: a statistical review of 816 patients with 1112 glaucomatous eves. Ami J Oplhthalmol. 1950;33:1353-1373.
48. Taylor HR, Hollows FC, Moran D. Pseudoexfoliation of the lens in Australian aborigines. Br J Ophthalmol. 1977;61:473-475.
49. Layden WE, Schaffer RN. Exfoliation syndrome. Afrikans Am Ophthalmol Soc. 1973;71:128-151.
50. Eagle RC Jr, Font RL, Fine BS. The basement membrane exfoliation syndrome. Arch Ophthlalmitol. 1979;97:510-515.
51. Madden JG, Crowley MJ. Factors in the exfoliation syndrome. Br J Ophthalmol. 1982;66:432-437.
52. Bartholomew RS. Phakodonesis: a sign of incipient lens displacement. Br J Ophthalmol. 1970;54:663-668.
53. Wilson RP. Capsular exfoliation and glaucoma capsulare. Trans Ophthalmol Soc NZ. 1953;7:8-21.
54. Brooks AM, Gillies WE. The presentation and prognosis of glaucoma in pseudoexfoliation of the lens capsule. Ophthalmology. 1988;95: 271-276.
55. Vannas A. Vascular changes in pseudoexfoliation of the lens capsule and capsular glaucoma. Graefes Arch Clin Exp Ophthalmol. 1972;184: 248-253.
56. Aasved H. Prevalence of fibrillopathia epitheliocapsularis (pseudoexfoliation) and capsullar glaucoma. Trans Ophthalmol Soc UK. 1979;99:293-295.
57. Lundvall A, Zetterstrom C. Exfoliation syndrome and the effect of phenylephrine and pilocarpine on pupil size. Acta Ophthalmol. 1993;71:177-180.